Growth Metrics

Accuray (ARAY) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Accuray 47,295.88 -38.49 Mn 25.29 Mn 70.59%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 70.59%
Dec 31, 2025 -256.43%
Sep 30, 2025 -241.43%
Mar 31, 2025 -63.30%
Dec 31, 2024 -25.70%
Sep 30, 2024 -2.56%
Mar 31, 2024 33.35%
Dec 31, 2023 18.58%
Sep 30, 2023 14.15%
Mar 31, 2023 -41.67%
Dec 31, 2022 -91.03%
Sep 30, 2022 12.64%
Mar 31, 2022 -120.52%
Dec 31, 2021 -18.61%
Sep 30, 2021 -155.89%
Mar 31, 2021 -275.56%
Dec 31, 2020 46.52%
Sep 30, 2020 55.09%
Jun 30, 2020 26.14%
Mar 31, 2020 60.61%
Dec 31, 2019 -105.52%
Sep 30, 2019 20.91%
Jun 30, 2019 31.57%
Mar 31, 2019 -104.79%
Dec 31, 2018 37.65%
Sep 30, 2018 -72.44%
Jun 30, 2018 9.97%
Mar 31, 2018 46.52%
Dec 31, 2017 -3,306.90%
Sep 30, 2017 -118.25%
Jun 30, 2017 -108.25%
Mar 31, 2017 381.56%
Dec 31, 2016 98.95%
Sep 30, 2016 202.17%
Jun 30, 2016 241.69%
Mar 31, 2016 -97.17%
Dec 31, 2015 71.77%
Sep 30, 2015 -116.05%
Jun 30, 2015 -479.50%
Mar 31, 2015 -1,927.27%
Dec 31, 2014 -266.32%
Sep 30, 2014 2,197.30%
Jun 30, 2014 103.72%
Mar 31, 2014 105.92%
Dec 31, 2013 251.57%
Sep 30, 2013 84.28%
Jun 30, 2013 -3,366.71%
Mar 31, 2013 36.71%
Dec 31, 2012 -33.84%
Sep 30, 2012 -295.63%
Jun 30, 2012 -119.88%
Mar 31, 2012 -123.86%
Dec 31, 2011 51.91%
Sep 30, 2011 -138.99%